POM FiO2 Conclusion of Piper Medical Study

PROTOCOL:

Oxygen Delivery Testing of the POM Procedural Oxygen Mask Under Simulated Patient Conditions

RESULTS:

POM (Procedural Oxygen Mask) FiO2 Results
Rate = 12 BPM, TV = 400 ml, I:E Ratio = 1:1, ETCO2 % = 3%

Sample #

Medium Oxygen Flow Adaptor

O2 Flow = 8 l/min

O2 Flow = 10 l/min

O2 Flow = 12 l/min

  1

  2

  3

78.4%

76.8%

77.5%

84.4%

83.8%

82.0%

87.6%

88.1%

85.2%

Mean

Std Dev

77.6%

0.8%

83.4%

1.2%

87.0%

1.6%

High Concentration Adaptor

O2 Flow = 10 l/min

O2 Flow = 12 l/min

O2 Flow = 15 l/min

  1

  2

  3

89.2%

88.4%

87.0%

91.6%

92.2%

90.1%

95.6%

97.1%

93.8%

Mean

Std Dev

88.2%

1.1%

91.3%

1.1%

95.5%

1.7%

The overall results from the Piper Medical FiO2 study has exceeded POM Medical’s expectations of the anticipated results. In a simulated (spontaneously) breathing patient, the medium concentration POM model was able to achieve up to 88.1% FiO2 delivered to the patient.

Given the exact same protocol performed with the high concentration model, The POM was able to achieve an outstanding 97% FiO2 delivered to the patient. These results greatly supersede the functionality of other traditional oxygen masks as well as nasal cannulas.

The POM can outperform most free-flowing oxygen masks on the market. With The POM’s ability to provide ultimate access to the patient’s nose or mouth while monitoring end-tidal CO2, and also providing these high FiO2 percentages, it can be easily concluded that the Procedural Oxygen Mask will become the standard of care for all upper endoscopy procedures under conscious sedation.

During the course of this study, POM Medical was unable to find evidence of any free-flowing oxygen mask on the market which can claim a FiO2 delivery of over 90%.

It is POM Medical’s goal that you have found the conclusion of this study beneficial in examining the FiO2 functionality of The Procedural Oxygen Mask.